Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2010

View Archived Issues

Preclinical and first-in-human data reported on GSK-1292263 for type 2 diabetes

PCDH10 gene methylation status is biomarker for risk of cervical cancer in hrHPV infection

A-918446 and A-801195 show preclinical promise for treatment of AD

Biomarkers of oxidative stress correlate with HPV clearance

Taspoglutide is superior to comparators in improving glycemic control in phase III diabetes trials

Mesoblast to manufacture and supply adult stem cell products in Australia

Lilly acquires Alnara Pharmaceuticals

Prolor Biotech's hGH-CTP enters phase II trial in growth hormone deficiency

Access Pharma and BioScrip sign MuGard distribution agreement

Novartis' Rasilez approved in China for high blood pressure

Pharmasset claims new NS5B inhibitors

Merck & Co. discloses new gamma-secretase modulators

Health Canada grants priority review for Prochymal NDS

New PLK-1 inhibitors discovered by Rigel

Gilead Sciences reports highlights of second quarter 2010

Sirtris Pharmaceuticals describes new sirtuin modulators

Curis identifies novel CDK inhibitors

Abbott updates developments of second quarter 2010

Ampio begins phase II trial of oral Optina in diabetic macular edema

Fera Pharmaceuticals acquires itraconazole topical suspension

GSK suspends enrollment in TIDE trial at FDA's request

Tamir agents are efficacious against SARS virus in vitro

Onyx begins phase III carfilzomib combination trial in relapsed multiple myeloma

FDA recommends further naproxcinod trials in complete response letter to NicOx

Preliminary phase IIb data disclosed on S/GSK-1349572 for HIV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...